Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice
Authors:
- 15 April 2024
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 73 (7) , 1081-1098
Abstract
Background Tsumura-Suzuki non-obese (TSNO) mice exhibit a severe form of metabolic dysfunction-associated steatohepatitis (MASH) with advanced liver fibrosis upon feeding a high-fat/cholesterol/cholate-based (iHFC) diet. Another ddY strain, Tsumura-Suzuki diabetes obese (TSOD) mice, are impaired in the progression of iHFC diet-induced MASH. Aim To elucidate the underlying mechanisms contributing to the differences in MASH progression between TSNO and TSOD mice. Methods We analyzed differences in the immune system, gut microbiota, and bile acid metabolism in TSNO and TSOD mice fed with a normal diet (ND) or an iHFC diet. Results TSOD mice had more anti-inflammatory macrophages in the liver than TSNO mice under ND feeding, and were impaired in the iHFC diet-induced accumulation of fibrosis-associated macrophages and formation of histological hepatic crown-like structures in the liver. The gut microbiota of TSOD mice also exhibited a distinct community composition with lower diversity and higher abundance of Akkermansia muciniphila compared with that in TSNO mice. Finally, TSOD mice had lower levels of bile acids linked to intestinal barrier disruption under iHFC feeding. Conclusions The dynamics of liver macrophage subsets, and the compositions of the gut microbiota and bile acids at steady state and post-onset of MASH, had major impacts on MASH development.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP22K07005)
- Toyama Pharmaceutical Valley Development Consortium
This publication has 56 references indexed in Scilit:
- Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectivesFrontiers of Medicine, 2022
- Isoliquiritigenin Attenuates Adipose Tissue Inflammation and Metabolic Syndrome by Modifying Gut Bacteria Composition in MiceMolecular Nutrition & Food Research, 2022
- Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β‐Muricholic Acid, a Farnesoid X Receptor AntagonistLipids, 2017
- Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in MiceHepatology, 2013
- Intestinal microbiota in patients with nonalcoholic fatty liver diseaseHepatology, 2013
- Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASHHepatology, 2012
- Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits HypothesisHepatology, 2010
- Expression and function of the bile acid receptor TGR5 in Kupffer cellsBiochemical and Biophysical Research Communications, 2008
- Bile acids and cytokines inhibit the human cholesterol 7α‐hydroxylase gene via the JNK/c‐jun pathway in human liver cells†Hepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005